Among these key genetic alterations, EGFR amplification plays a key role in GBM oncogenesis, with increasing age‐associated nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB)‐driven inflammation further exacerbating EGFR dysregulation [13]. The gene discussed is EGFR; the disease is glioblastoma.